Cost-Effectiveness of Simeprevir Vs. Telaprevir for The Triple Therapy of Hepatitis C In Kazakhstan
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2209
https://www.valueinhealthjournal.com/article/S1098-3015(15)04285-0/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
1625
First Page :
A627
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04285-0&doi=10.1016/j.jval.2015.09.2209